RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 118 filers reported holding RHYTHM PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $320,642 | -41.4% | 7,400 | -37.8% | 0.00% | -100.0% |
| Q4 2023 | $547,043 | +100.5% | 11,900 | 0.0% | 0.00% | – |
| Q3 2023 | $272,808 | +39.0% | 11,900 | 0.0% | 0.00% | – |
| Q2 2023 | $196,231 | -7.6% | 11,900 | 0.0% | 0.00% | – |
| Q1 2023 | $212,296 | -38.7% | 11,900 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $346,528 | +18.7% | 11,900 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $292,000 | – | 11,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 735,000 | $13,112,400 | 3.93% |
| NEA Management Company, LLC | 2,909,956 | $51,913,615 | 3.59% |
| Frazier Life Sciences Management, L.P. | 2,164,739 | $38,618,944 | 2.80% |
| RA Capital Management | 5,516,067 | $98,406,635 | 2.23% |
| Samsara BioCapital, LLC | 345,293 | $6,160,027 | 1.27% |
| Rock Springs Capital Management LP | 1,597,123 | $28,492,674 | 0.68% |
| Baker Brothers Advisors | 6,498,267 | $115,929,083 | 0.63% |
| HighVista Strategies LLC | 35,478 | $632,928 | 0.52% |
| Nan Fung Group Holdings Ltd | 32,520 | $580,157 | 0.40% |
| GREAT POINT PARTNERS LLC | 97,544 | $1,740,185 | 0.34% |